Delivery Order SPE2DB25D9305-SPE2DB25FQAJF
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $19,405.50 to DMS Pharmaceutical Group Inc. for 200-unit vials of Botox, with an ultimate completion date of September 23, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The product will be delivered to Park Ridge, Illinois and will support pharmaceutical supply needs within the federal...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,937.00 to DMS Pharmaceutical Group Inc. for the supply of Botox 200 unit vials. The contract, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, represents a standard procurement with no set-aside designation. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery from its Illinois location. This...
- The Defense Logistics Agency awarded a delivery order valued at $18,502.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 Unit Vials. The delivery order carries a firm fixed-price structure with an ultimate completion date of September 19, 2025, and was processed without a set-aside designation. This award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the...
- The Defense Logistics Agency awarded a delivery order valued at $11,101.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 Unit Vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and carries no set-aside designation. This award represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,881.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The contract, issued under firm fixed-price terms with an ultimate completion date of September 4, 2025, represents a specific purchase order executed without set-aside designation. DMS Pharmaceutical Group, registered in the System for Award Management since...
- The Defense Logistics Agency awarded a delivery order valued at $9,251.40 to DMS Pharmaceutical Group Inc. for BOTOX 100 unit vials on August 13, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order was issued without a set-aside designation and will be performed at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected as the awardee based on its established...
- The Defense Logistics Agency awarded a delivery order valued at $2,587.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,937.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The contract, effective August 19, 2025, with an ultimate completion date of September 10, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA's...
- The Defense Logistics Agency awarded a delivery order valued at $1,940.55 to DMS Pharmaceutical Group Inc. for Botox 200-unit vials. This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, represents a pharmaceutical supply requirement fulfilled through DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA. The award carries no set-aside designation, allowing the woman-owned small business to compete on an...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $97,027.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The delivery order, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, carries no set-aside designation. This award represents a discrete fulfillment order issued under DMS Pharmaceutical Group's larger Indefinite...
- SPE2DB25D9305Indefinite Delivery Contract
- SPE2DB25D9305-SPE2DB25FQAJFDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,312.85 to DMS Pharmaceutical Group Inc. for the supply of Botox 100 unit vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order carries an ultimate completion date of September 24, 2025, and represents a specific fulfillment under the company's broader procurement relationship with the federal government. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026, which authorizes firm fixed-price orders for pharmaceutical products supporting military health facility supply chains worldwide. The company has established itself as a critical supplier within the federal pharmaceutical distribution network, providing an extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. The Botox procurement reflects the specialized pharmaceutical and medical supply requirements fulfilled through this master contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/3/25 |